KALA BIO
KALA
21 hedge funds and large institutions have $3.69M invested in KALA BIO in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
5% more funds holding
Funds holding: 20 → 21 (+1)
0.01% less ownership
Funds ownership: 0.4% → 0.39% (-0.01%)
19% less capital invested
Capital invested by funds: $4.57M → $3.69M (-$880K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$99.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$30.8K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$17.7K |
| 4 |
KOCAA
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
+$17.3K |
| 5 |
Morgan Stanley
New York
|
+$11.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$108K |
| 2 |
Millennium Management
New York
|
-$12K |
| 3 |
C
Covestor
London,
United Kingdom
|
-$708 |
| 4 |
PFBT
Parkside Financial Bank & Trust
Saint Louis,
Missouri
|
-$339 |
| 5 |
BONH
Bank of New Hampshire
Laconia,
New Hampshire
|
-$9 |
KALA Hedge Fund Activity: Q4 2023 in Review
21 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2023, worth a combined $3.69M — down 19% from $4.57M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new KALA positions and 2 closed out — a net gain of 1 holder — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $99.8K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $108K sold.
- 21 institutional investors held KALA BIO (KALA) as of Q4 2023, up from 20 in Q3 2023.
- Funds reported $3.69M of KALA BIO stock for Q4 2023, down 19% quarter-over-quarter.
- 3 funds opened new KALA BIO positions in Q4 2023 and 2 closed out, a net change of +1 holder.
- The largest KALA BIO buyer in Q4 2023 was Renaissance Technologies, an estimated $99.8K added.
- The largest KALA BIO seller in Q4 2023 was Dimensional Fund Advisors, an estimated $108K sold.
Based on aggregated 13F filings for Q4 2023.